Advertisement
Screener

Pacific Biosciences of California, Inc. (PACB) Gross Profit

Pacific Biosciences of California, Inc. Gross Profit

Pacific Biosciences of California, Inc. (PACB) reported Gross Profit of $12.64 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement

us-gaap:GrossProfit · last filed 2026-08-06

  • Pacific Biosciences of California, Inc. gross profit for the quarter ending 2026-06-30 was $12.64M, a 13.93% decline year-over-year.
  • Pacific Biosciences of California, Inc. gross profit for the quarter ending 2026-03-31 was $12.84M.
  • Pacific Biosciences of California, Inc. gross profit for the quarter ending 2025-12-31 was $16.57M, a 64.70% increase year-over-year.
  • Pacific Biosciences of California, Inc. gross profit for the quarter ending 2025-09-30 was $15.90M, a 58.95% increase year-over-year.
  • Pacific Biosciences of California, Inc. gross profit for fiscal 2025 was $45.78M, a 22.79% increase from fiscal 2024.
  • Pacific Biosciences of California, Inc. gross profit for fiscal 2024 was $37.28M, a 29.36% decline from fiscal 2023.
  • Pacific Biosciences of California, Inc. gross profit for fiscal 2023 was $52.78M, a 7.64% increase from fiscal 2022.
  • Pacific Biosciences of California, Inc. gross profit for fiscal 2022 was $49.03M, a 16.69% decline from fiscal 2021.
Period endGross Profit 3 monthGross Profit 6 monthGross Profit 9 monthGross Profit 12 month
2026-06-30$12.64M
10-Q · filed 2026-08-06
$25.48M
10-Q · filed 2026-08-06
$42.05M
derived: sum of 3 quarters · filed 2026-08-06
$57.95M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$12.84M
10-Q · filed 2026-05-08
$29.41M
derived: sum of 2 quarters · filed 2026-05-08
$45.31M
derived: sum of 3 quarters · filed 2026-05-08
$59.99M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$16.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$32.47M
derived: sum of 2 quarters · filed 2026-02-25
$47.15M
derived: sum of 3 quarters · filed 2026-08-06
$45.78M
10-K · filed 2026-02-25
2025-09-30$15.90M
10-Q · filed 2025-11-06
$30.59M
derived: sum of 2 quarters · filed 2026-08-06
$29.21M
10-Q · filed 2025-11-06
$39.27M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$14.68M
10-Q · filed 2026-08-06
$13.31M
10-Q · filed 2026-08-06
$23.37M
derived: sum of 3 quarters · filed 2026-08-06
$33.38M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$1.37M
10-Q · filed 2026-05-08
$8.69M
derived: sum of 2 quarters · filed 2026-05-08
$18.69M
derived: sum of 3 quarters · filed 2026-05-08
$24.63M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$10.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$20.06M
derived: sum of 2 quarters · filed 2026-02-25
$26.00M
derived: sum of 3 quarters · filed 2026-02-25
$37.28M
10-K · filed 2026-02-25
2024-09-30$10.00M
10-Q · filed 2025-11-06
$15.94M
derived: sum of 2 quarters · filed 2025-11-06
$27.22M
10-Q · filed 2025-11-06
$36.80M
derived: sum of 4 quarters · filed 2026-02-25
2024-06-30$5.94M
10-Q · filed 2025-08-07
$17.22M
10-Q · filed 2025-08-07
$26.79M
derived: sum of 3 quarters · filed 2026-02-25
$44.69M
derived: sum of 4 quarters · filed 2026-02-25
2024-03-31$11.28M
10-Q · filed 2025-05-12
$20.85M
derived: sum of 2 quarters · filed 2026-02-25
$38.76M
derived: sum of 3 quarters · filed 2026-02-25
$54.30M
derived: sum of 4 quarters · filed 2026-02-25
2023-12-31$9.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$27.47M
derived: sum of 2 quarters · filed 2026-02-25
$43.02M
derived: sum of 3 quarters · filed 2026-02-25
$52.78M
10-K · filed 2026-02-25
2023-09-30$17.90M
10-Q · filed 2024-11-12
$33.45M
derived: sum of 2 quarters · filed 2024-11-12
$43.21M
10-Q · filed 2024-11-12
$48.35M
derived: sum of 4 quarters · filed 2025-03-17
2023-06-30$15.55M
10-Q · filed 2024-08-09
$25.31M
10-Q · filed 2024-08-09
$30.45M
derived: sum of 3 quarters · filed 2025-03-17
$43.99M
derived: sum of 4 quarters · filed 2025-03-17
2023-03-31$9.76M
10-Q · filed 2024-05-09
$14.90M
derived: sum of 2 quarters · filed 2025-03-17
$28.45M
derived: sum of 3 quarters · filed 2025-03-17
$44.64M
derived: sum of 4 quarters · filed 2025-03-17
2022-12-31$5.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17
$18.69M
derived: sum of 2 quarters · filed 2025-03-17
$34.88M
derived: sum of 3 quarters · filed 2025-03-17
$49.03M
10-K · filed 2025-03-17
2022-09-30$13.55M
10-Q · filed 2023-11-03
$29.74M
derived: sum of 2 quarters · filed 2023-11-03
$43.90M
10-Q · filed 2023-11-03
$60.66M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30$16.19M
10-Q · filed 2023-08-04
$30.35M
10-Q · filed 2023-08-04
$47.11M
derived: sum of 3 quarters · filed 2024-02-28
$62.48M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31$14.15M
10-Q · filed 2023-05-04
$30.92M
derived: sum of 2 quarters · filed 2024-02-28
$46.28M
derived: sum of 3 quarters · filed 2024-02-28
$60.04M
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31$16.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$32.13M
derived: sum of 2 quarters · filed 2024-02-28
$45.88M
derived: sum of 3 quarters · filed 2024-02-28
$58.86M
10-K · filed 2024-02-28
2021-09-30$15.36M
10-Q · filed 2022-11-08
$29.12M
derived: sum of 2 quarters · filed 2022-11-08
$42.09M
10-Q · filed 2022-11-08
$53.49M
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30$13.75M
10-Q · filed 2022-08-08
$26.73M
10-Q · filed 2022-08-08
$38.13M
derived: sum of 3 quarters · filed 2023-02-28
$45.20M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31$12.98M
10-Q · filed 2022-05-06
$24.38M
derived: sum of 2 quarters · filed 2023-02-28
$31.44M
derived: sum of 3 quarters · filed 2023-02-28
$38.05M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31$11.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$18.46M
derived: sum of 2 quarters · filed 2023-02-28
$25.08M
derived: sum of 3 quarters · filed 2023-02-28
$32.57M
10-K · filed 2023-02-28
2020-09-30$7.06M
10-Q · filed 2021-11-05
$13.68M
derived: sum of 2 quarters · filed 2021-11-05
$21.16M
10-Q · filed 2021-11-05
$34.10M
derived: sum of 4 quarters · filed 2021-11-05
2020-06-30$6.61M
10-Q · filed 2021-08-06
$14.10M
10-Q · filed 2021-08-06
$27.03M
derived: sum of 3 quarters · filed 2021-08-06
$33.95M
derived: sum of 4 quarters · filed 2021-08-06
2020-03-31$7.49M
10-Q · filed 2021-05-06
$20.42M
derived: sum of 2 quarters · filed 2021-05-06
$27.33M
derived: sum of 3 quarters · filed 2021-05-06
$36.95M
derived: sum of 4 quarters · filed 2021-05-06
2019-12-31$12.93M
10-K · filed 2020-02-28
$19.85M
derived: sum of 2 quarters · filed 2020-11-03
$29.46M
derived: sum of 3 quarters · filed 2020-11-03
$34.58M
10-K · filed 2022-02-28
2019-09-30$6.91M
10-Q · filed 2020-11-03
$16.53M
derived: sum of 2 quarters · filed 2020-11-03
$21.64M
10-Q · filed 2020-11-03
$27.39M
derived: sum of 4 quarters · filed 2020-11-03
2019-06-30$9.61M
10-Q · filed 2020-08-06
$14.73M
10-Q · filed 2020-08-06
$20.48M
derived: sum of 3 quarters · filed 2020-08-06
$23.67M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31$5.12M
10-Q · filed 2020-05-08
$10.86M
derived: sum of 2 quarters · filed 2020-05-08
$14.05M
derived: sum of 3 quarters · filed 2020-05-08
$22.92M
derived: sum of 4 quarters · filed 2020-05-08
2018-12-31$5.75M
10-K · filed 2020-02-28
$8.94M
derived: sum of 2 quarters · filed 2020-02-28
$17.80M
derived: sum of 3 quarters · filed 2020-02-28
$25.10M
10-K · filed 2021-02-26
2018-09-30$3.19M
10-K · filed 2020-02-28
$12.05M
derived: sum of 2 quarters · filed 2020-02-28
$19.35M
10-Q · filed 2019-11-07
$28.84M
derived: sum of 4 quarters · filed 2020-02-28
2018-06-30$8.86M
10-K · filed 2020-02-28
$16.16M
10-Q · filed 2019-08-06
$25.65M
derived: sum of 3 quarters · filed 2020-02-28
$33.88M
derived: sum of 4 quarters · filed 2020-02-28
2018-03-31$7.30M
10-K · filed 2020-02-28
$16.79M
derived: sum of 2 quarters · filed 2020-02-28
$25.02M
derived: sum of 3 quarters · filed 2020-02-28
$33.02M
derived: sum of 4 quarters · filed 2020-02-28
2017-12-31$9.49M
10-K · filed 2019-02-26
$17.72M
derived: sum of 2 quarters · filed 2019-02-26
$25.72M
derived: sum of 3 quarters · filed 2019-02-26
$34.66M
10-K · filed 2020-02-28
2017-09-30$8.23M
10-K · filed 2019-02-26
$16.23M
derived: sum of 2 quarters · filed 2019-02-26
$25.16M
10-Q · filed 2018-11-05
$36.54M
derived: sum of 4 quarters · filed 2019-02-26
2017-06-30$8.00M
10-K · filed 2019-02-26
$16.94M
10-Q · filed 2018-08-03
$28.31M
derived: sum of 3 quarters · filed 2019-02-26
$40.95M
derived: sum of 4 quarters · filed 2019-02-26
2017-03-31$8.94M
10-K · filed 2019-02-26
$20.31M
derived: sum of 2 quarters · filed 2019-02-26
$32.95M
derived: sum of 3 quarters · filed 2019-02-26
$43.59M
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31$11.37M
10-K · filed 2018-02-26
$24.01M
derived: sum of 2 quarters · filed 2018-02-26
$34.66M
derived: sum of 3 quarters · filed 2018-02-26
$44.16M
10-K · filed 2019-02-26
2016-09-30$12.64M
10-K · filed 2018-02-26
$23.28M
derived: sum of 2 quarters · filed 2018-02-26
$32.79M
10-Q · filed 2017-11-02
$59.25M
derived: sum of 4 quarters · filed 2018-02-26
2016-06-30$10.64M
10-K · filed 2018-02-26
$20.15M
10-Q · filed 2017-08-02
$46.61M
derived: sum of 3 quarters · filed 2018-02-26
$53.16M
derived: sum of 4 quarters · filed 2018-02-26
2016-03-31$9.50M
10-K · filed 2018-02-26
$35.97M
derived: sum of 2 quarters · filed 2018-02-26
$42.52M
derived: sum of 3 quarters · filed 2018-02-26
$57.03M
derived: sum of 4 quarters · filed 2018-02-26
2015-12-31$26.47M
10-K · filed 2017-03-06
$33.02M
derived: sum of 2 quarters · filed 2017-03-06
$47.52M
derived: sum of 3 quarters · filed 2017-03-06
$53.45M
10-K · filed 2018-02-26
2015-09-30$6.55M
10-K · filed 2017-03-06
$21.06M
derived: sum of 2 quarters · filed 2017-03-06
$26.98M
10-Q · filed 2016-11-04
$31.42M
derived: sum of 4 quarters · filed 2017-03-06
2015-06-30$14.51M
10-K · filed 2017-03-06
$20.43M
10-Q · filed 2016-08-04
$24.87M
derived: sum of 3 quarters · filed 2017-03-06
$38.03M
derived: sum of 4 quarters · filed 2017-03-06
2015-03-31$5.93M
10-K · filed 2017-03-06
$10.37M
derived: sum of 2 quarters · filed 2017-03-06
$23.53M
derived: sum of 3 quarters · filed 2017-03-06
$26.65M
derived: sum of 4 quarters · filed 2017-03-06
2014-12-31$4.44M
10-K · filed 2016-03-11
$17.60M
derived: sum of 2 quarters · filed 2016-03-11
$20.73M
derived: sum of 3 quarters · filed 2016-03-11
$23.40M
10-K · filed 2017-03-06
2014-09-30$13.16M
10-K · filed 2016-03-11
$16.29M
derived: sum of 2 quarters · filed 2016-03-11
$18.96M
10-Q · filed 2015-11-05
$22.15M
derived: sum of 4 quarters · filed 2016-03-11
2014-06-30$3.13M
10-K · filed 2016-03-11
$5.80M
10-Q · filed 2015-08-05
$8.99M
derived: sum of 3 quarters · filed 2016-03-11
$10.23M
derived: sum of 4 quarters · filed 2016-03-11
2014-03-31$2.68M
10-K · filed 2016-03-11
$5.87M
derived: sum of 2 quarters · filed 2016-03-11
$7.11M
derived: sum of 3 quarters · filed 2016-03-11
$8.16M
derived: sum of 4 quarters · filed 2016-03-11
2013-12-31$3.19M
10-K · filed 2015-03-12
$4.43M
derived: sum of 2 quarters · filed 2015-03-12
$5.49M
derived: sum of 3 quarters · filed 2015-03-12
$6.42M
10-K · filed 2016-03-11
2013-09-30$1.24M
10-K · filed 2015-03-12
$2.30M
derived: sum of 2 quarters · filed 2015-03-12
$3.23M
10-Q · filed 2014-11-05
$3.86M
derived: sum of 4 quarters · filed 2015-03-12
2013-06-30$1.06M
10-K · filed 2015-03-12
$1.99M
10-Q · filed 2014-08-05
$2.62M
derived: sum of 3 quarters · filed 2015-03-12
$2.81M
derived: sum of 4 quarters · filed 2015-03-12
2013-03-31$930.00K
10-K · filed 2015-03-12
$1.56M
derived: sum of 2 quarters · filed 2015-03-12
$1.75M
derived: sum of 3 quarters · filed 2015-03-12
$2.02M
derived: sum of 4 quarters · filed 2015-03-12
2012-12-31$627.00K
10-K · filed 2014-03-14
$817.00K
derived: sum of 2 quarters · filed 2014-03-14
$1.09M
derived: sum of 3 quarters · filed 2014-03-14
$940.00K
10-K · filed 2015-03-12
2012-09-30$190.00K
10-K · filed 2014-03-14
$465.00K
derived: sum of 2 quarters · filed 2014-03-14
$313.00K
10-Q · filed 2013-11-12
$1.85M
derived: sum of 4 quarters · filed 2014-03-14
2012-06-30$275.00K
10-K · filed 2014-03-14
$123.00K
10-Q · filed 2013-08-09
$1.66M
derived: sum of 3 quarters · filed 2014-03-14
$4.99M
derived: sum of 4 quarters · filed 2014-03-14
2012-03-31-$152.00K
10-K · filed 2014-03-14
$1.39M
derived: sum of 2 quarters · filed 2014-03-14
$4.71M
derived: sum of 3 quarters · filed 2014-03-14
$12.61M
derived: sum of 4 quarters · filed 2014-03-14
2011-12-31$1.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14
$4.87M
derived: sum of 2 quarters · filed 2014-03-14
$12.76M
derived: sum of 3 quarters · filed 2014-03-14
$13.03M
10-K · filed 2014-03-14
2011-09-30$3.33M
10-Q · filed 2012-11-01
$11.23M
derived: sum of 2 quarters · filed 2012-11-01
$11.50M
10-Q · filed 2012-11-01
$11.78M
derived: sum of 4 quarters · filed 2013-03-15
2011-06-30$7.90M
10-Q · filed 2012-08-07
$8.17M
10-Q · filed 2012-08-07
$8.45M
derived: sum of 3 quarters · filed 2013-03-15
$8.67M
derived: sum of 4 quarters · filed 2013-03-15
2011-03-31$270.00K
10-Q · filed 2012-05-07
$550.00K
derived: sum of 2 quarters · filed 2013-03-15
$770.00K
derived: sum of 3 quarters · filed 2013-03-15
$1.40M
derived: sum of 4 quarters · filed 2013-03-15
2010-12-31$280.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15
$500.00K
derived: sum of 2 quarters · filed 2013-03-15
$1.13M
derived: sum of 3 quarters · filed 2013-03-15
$1.67M
10-K · filed 2013-03-15
2010-09-30$220.00K
10-Q · filed 2011-11-14
$849.00K
derived: sum of 2 quarters · filed 2011-11-14
$1.39M
10-Q · filed 2011-11-14
2010-06-30$629.00K
10-Q · filed 2011-08-12
$1.17M
10-Q · filed 2011-08-12
2009-12-31$135.00K
10-K · filed 2012-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B